Study Using CP-461 to Treat Advanced Prostate Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether an investigational drug, CP-461, is safe
and effective for the treatment of patients with prostate cancer and who have measurable
disease.